Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

If You Use a Screen Reader

This content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.

Murine Gammaherpesvirus M2 Gene Is Latency-Associated and Its Protein a Target for CD8+ T Lymphocytes

S. Mazher Husain, Edward J. Usherwood, Heather Dyson, Christopher Coleclough, Michael A. Coppola, David L. Woodland, Marcia A. Blackman, James P. Stewart and Jeffery T. Sample
Proceedings of the National Academy of Sciences of the United States of America
Vol. 96, No. 13 (Jun. 22, 1999), pp. 7508-7513
Stable URL: http://www.jstor.org/stable/48089
Page Count: 6
  • Read Online (Free)
  • Subscribe ($19.50)
  • Cite this Item
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Murine Gammaherpesvirus M2 Gene Is Latency-Associated and Its Protein a Target for CD8+ T Lymphocytes
Preview not available

Abstract

Murine gammaherpesvirus 68 (MHV-68) infection of mice is a potential model with which to address fundamental aspects of the pathobiology and host control of gammaherpesvirus latency. Control of MHV-68 infection, like that of Epstein-Barr virus, is strongly dependent on the cellular immune system. However, the molecular biology of MHV-68 latency is largely undefined. A screen of the MHV-68 genome for potential latency-associated mRNAs revealed that the region encompassing and flanking the genomic terminal repeats is transcriptionally active in the latently infected murine B-cell tumor line S11. Transcription of one MHV-68 gene, that encoding the hypothetical M2 protein, was detected in virtually all latently infected S11 cells and in splenocytes of latently infected mice, but not in lytically infected fibroblasts. Furthermore, an epitope was identified in the predicted M2 protein that is recognized by CD8+ T cells from infected mice and a cytotoxic T lymphocyte line that recognizes this epitope killed S11 cells, indicating that the M2 protein is expressed during latent infection and is a target for the host cytotoxic T lymphocyte response. This work therefore provides essential information for modeling MHV-68 latency and strategies of immunotherapy against gammaherpesvirus-related diseases in a highly tractable animal model.

Page Thumbnails

  • Thumbnail: Page 
7508
    7508
  • Thumbnail: Page 
7509
    7509
  • Thumbnail: Page 
7510
    7510
  • Thumbnail: Page 
7511
    7511
  • Thumbnail: Page 
7512
    7512
  • Thumbnail: Page 
7513
    7513